Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXNX
2951
DELISTED
Axonics, Inc. Common Stock
AXNX
| $591K | ﹤0.01% |
9,316
-16,231
| -64% | -$958K |
|
|
HYRE
2952
DELISTED
HyreCar Inc. Common Stock
HYRE
| $591K | ﹤0.01% |
28,267
+20,660
| +272% | +$318K |
|
|
NTUS
2953
DELISTED
Natus Medical Inc
NTUS
| $591K | ﹤0.01% |
22,747
-24,514
| -52% | -$667K |
|
|
CUK
2954
DELISTED
Carnival PLC
CUK
| $590K | ﹤0.01% |
+25,358
| New | +$610K |
|
2955
PUT
Stratasys
SSYS
$763M
| $590K | ﹤0.01% |
22,800
| – | – |
|
2956
Daktronics
DAKT
$1.05B
| $589K | ﹤0.01% |
89,396
-26,124
| -23% | -$171K |
|
2957
Century Aluminum
CENX
$4.79B
| $588K | ﹤0.01% |
45,500
-17,537
| -28% | -$253K |
|
2958
CALL
ProShares UltraPro QQQ
TQQQ
$36.7B
| $588K | ﹤0.01% |
19,200
-36,800
| -66% | -$971K |
|
2959
CALL
Ulta Beauty
ULTA
$23.1B
| $588K | ﹤0.01% |
1,700
| – | – |
|
|
AGNT
2960
AGNT Inc
AGNT
$690M
| $587K | ﹤0.01% |
15,146
-64,828
| -81% | -$2.23M |
|
2961
Invesco S&P 500 High Beta ETF
SPHB
$1.02B
| $587K | ﹤0.01% |
+7,768
| New | +$576K |
|
2962
EverQuote
EVER
$832M
| $586K | ﹤0.01% |
17,947
+4,043
| +29% | +$135K |
|
2963
Ingles Markets
IMKTA
$1.66B
| $586K | ﹤0.01% |
10,069
-1,871
| -16% | -$116K |
|
2964
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $584K | ﹤0.01% |
1,873
-16,420
| -90% | -$4.94M |
|
2965
Acco Brands
ACCO
$408M
| $583K | ﹤0.01% |
67,642
-43,063
| -39% | -$383K |
|
2966
Golar LNG
GLNG
$5.17B
| $582K | ﹤0.01% |
43,988
-62,946
| -59% | -$749K |
|
2967
KT
KT
$8.83B
| $582K | ﹤0.01% |
41,769
-39,197
| -48% | -$536K |
|
2968
Seres Therapeutics
MCRB
$48M
| $582K | ﹤0.01% |
1,218
-1,533
| -56% | -$647K |
|
|
SCHW
2969
CALL
Charles Schwab
SCHW
$187B
| $582K | ﹤0.01% |
7,992
| – | – |
|
2970
Capital City Bank Group
CCBG
$900M
| $581K | ﹤0.01% |
22,503
-9,449
| -30% | -$245K |
|
2971
Schwab U.S Small- Cap ETF
SCHA
$22.9B
| $581K | ﹤0.01% |
+22,304
| New | +$570K |
|
2972
CALL
HCA Healthcare
HCA
$88.1B
| $579K | ﹤0.01% |
2,800
-4,400
| -61% | -$897K |
|
|
SMAR
2973
DELISTED
Smartsheet Inc.
SMAR
| $579K | ﹤0.01% |
8,001
+410
| +5% | +$25.6K |
|
2974
Alpha and Omega Semiconductor
AOSL
$1B
| $578K | ﹤0.01% |
19,036
-10,925
| -36% | -$336K |
|
|
PTR
2975
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $578K | ﹤0.01% |
11,760
-3,416
| -23% | -$139K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.